Biohaven Pharmaceutical Holding Company Ltd. IPO Research Information

Biohaven Pharmaceutical Holding Company Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Biohaven Pharmaceutical Holding Company Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Biohaven Pharmaceutical Holding Company Ltd.	BHVN - NYSE	$14.00-$16.00	$17.00	$20.00	9.9 million	5/4/2017
Underwriter(s): Morgan Stanley, Piper Jaffray, Barclays
Co-Manager(s): William Blair, Needham & Company
Industry: Health Care
Filing(s): Filed 2017-04-07 Terms Added 2017-04-24

Biohaven Pharmaceutical Holding Company Ltd. Quote & Chart - Click for current quote - BHVN

About Biohaven Pharmaceutical Holding Company Ltd. (adapted from Biohaven Pharmaceutical Holding Company Ltd. prospectus):
They are a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "BHVN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.